Medrx Co (TSE:4586) EV-to-Revenue : 180.25 (As of May. 26, 2024)

View and export this data going back to 2013. Start your Free Trial

What is Medrx Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Medrx Co's enterprise value is 円4,068.46 Mil. Medrx Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was 円22.57 Mil. Therefore, Medrx Co's EV-to-Revenue for today is 180.25.

The historical rank and industry rank for Medrx Co's EV-to-Revenue or its related term are showing as below:

TSE:4586' s EV-to-Revenue Range Over the Past 10 Years
Min: 4.45 Med: 107.5 Max: 635.21
Current: 180.25

During the past 13 years, the highest EV-to-Revenue of Medrx Co was 635.21. The lowest was 4.45. And the median was 107.50.

TSE:4586's EV-to-Revenue is ranked worse than
97.46% of 1024 companies
in the Drug Manufacturers industry
Industry Median: 2.285 vs TSE:4586: 180.25

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-26), Medrx Co's stock price is 円141.00. Medrx Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was 円0.59. Therefore, Medrx Co's PS Ratio for today is 239.39.

Medrx Co EV-to-Revenue Historical Data

The historical data trend for Medrx Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medrx Co EV-to-Revenue Chart

Medrx Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

16.24

20.32

173.00

28.37

137.89

Medrx Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															74.80	74.99	54.85	137.89	163.57

Competitive Comparison of Medrx Co's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Medrx Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medrx Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medrx Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Medrx Co's EV-to-Revenue falls into.

Medrx Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Medrx Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	4068.457	/	22.571
	=	180.25

Medrx Co's current Enterprise Value is 円4,068.46 Mil.
Medrx Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円22.57 Mil.

Medrx Co (TSE:4586) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Medrx Co's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	141.00	/	0.589
	=	239.39

Medrx Co's share price for today is 円141.00.
Medrx Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.59.

Medrx Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Medrx Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Medrx Co (TSE:4586) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medrx Co Ltd (TSE:4586) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

431-7 Nishiyama, Higashikagawa, Kagawa, JPN, 769-2712

Website

http://www.medrx.co.jp

Medrx Co Ltd is a pharmaceutical drug development company founded in January, 2002. The Company engaged in the research and development of pharmaceutical products utilizing the pharmaceutical formulation technology based on ionic liquid transdermal system. The Company develops new pharmaceutical candidates and licenses other companies to produce the pharmaceuticals after clinical trials. Its main products include analgesic patches for anti-inflammatory and pain relief.

Medrx Co (TSE:4586) Headlines

No Headlines